BridgeBio Pharma, Inc. (BBIO): SCHEDULE 13G/A filed Apr 16, 2026

Form type

SCHEDULE 13G/A

Filing date

Apr 16, 2026

Accession number

0001470831-26-000373

Filer

BridgeBio Pharma, Inc. (CIK 1743881)